Scientists at UMass Amherst and Ernest Pharmaceuticals developed BacID, a bacterial cancer therapy activated by aspirin. This ...

Scientists have made 'exciting,' patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly into tumors. This emerging technology holds ...

A University of Massachusetts Amherst-Ernest Pharmaceuticals team of scientists has made "exciting," patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver ...

Lynch syndrome, a genetic condition caused by germline mutations in DNA mismatch repair genes, significantly increases cancer ...

New research shows how regular aspirin use can lower cancer risk, especially for those with unhealthy lifestyles. Discover ...

Investopedia / Ryan Oakley A few factors make an employee non-exempt, such as being entitled to overtime pay, earning less than $684 a week per federal law, and holding executive, administrative ...

A surprisingly large amount of non-aspirin nonsteroidal anti-inflammatory drug (NAN-SAID) usage occurs in the United States, with estimates of as many as 30 billion tablets consumed per year.

Non-complementary bases on the newly synthesized DNA strand are recognized and excised, often with surrounding bases, to generate a gap that is repaired by copying the undamaged DNA strand.